ESA’s don’t improve quality of life in CKD anaemia

Evidence does not support using erythropoietin-stimulating agents to achieve higher haemoglobin levels in patients with chronic kidney disease and anaemia, a review concludes. The analysis of 17 studies published in this week’s Annals of Internal Medicine found patients randomised to a higher haemoglobin target had no clinically or statistically significant improvement in any measure of ...

Already a member?

Login to keep reading.

© 2021 the limbic